The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConcurrent Technologies Regulatory News (CNC)

Share Price Information for Concurrent Technologies (CNC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 102.00
Bid: 101.00
Ask: 103.00
Change: 0.00 (0.00%)
Spread: 2.00 (1.98%)
Open: 102.00
High: 102.00
Low: 102.00
Prev. Close: 102.00
CNC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Total Voting Rights & Director Shareholding

27 May 2020 16:55

RNS Number : 1305O
Concurrent Technologies PLC
27 May 2020
 

27 May 2020

 

Concurrent Technologies Plc

(the 'Company')

 

Total Voting Rights & Director Shareholding

 

Concurrent Technologies Plc (AIM: CNC) advises that it has transferred a total of 420,000 ordinary shares of 1p each ("Ordinary Shares") from Treasury in order to satisfy the exercise of share options.

After this transfer, the Company's total issued share capital consists of 73,900,012 Ordinary Shares, of which 331,522 are held in Treasury. Therefore, the total number of the Company's Ordinary Shares with voting rights is 73,568,490.

This figure of 73,568,490 may be used by shareholders as the denominator for calculations to determine if they have a notifiable interest in the Company under the FCA's Disclosure and Transparency Rules, or if such interest has changed.

A tranche of these transfers from Treasury related to the exercise by Ms Jane Annear, Managing Director, of options in respect of 400,000 Ordinary Shares at 39 pence each on 26 May 2020. In a separate transaction on 27 May 2020, Ms Annear also transferred 11,500 Ordinary Shares from her personal share dealing account to an individual savings account ("ISA") in her name as set out below.

 

Following completion of these transactions, Ms Annear has an interest in 2,255,096 ordinary shares, representing 3.1% of the issued share capital of the Company.

 

Enquiries:

 

Concurrent Technologies Plc Jane Annear, Managing Director/CEO

 

+44 (0)1206 752626

 

 

Newgate (Financial PR) Bob Huxford

Isabelle Smurfit

 

+44 (0)20 7653 9848+44 (0)20 3757 3411

 

 

Cenkos Securities Plc (NOMAD) Neil McDonald

Peter Lynch

+44 (0)131 220 9771

+44 (0)131 220 9772

 

Note to Editors:

 

About Concurrent Technologies Plc

 

Concurrent Technologies Plc develops and manufactures high-end embedded computer products for use in a wide range of high performance, long life cycle applications within the telecommunications, defence, security, telemetry, scientific and aerospace markets, including applications within extremely harsh environments. The processor products feature Intel® processors, including the latest 9th generation embedded Intel® Core™ processors, Intel® Xeon® and Intel® Atom™ processors. The products are designed to be compliant with industry specifications and support many of today's leading embedded Operating Systems. The products are sold world-wide.

 

For more information on Concurrent Technologies Plc and its products please visit www.gocct.com.

 

All trademarks, registered trademarks and trade names used in this announcement are the property of their respective owners.

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Jane Annear

2.

Reason for the Notification

a)

Position/status

Director

b)

Initial notification/amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Concurrent Technologies Plc

b)

LEI

213800422HXP2X6UPD94

4.

Details of the transaction(s):section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv)each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary shares of 1 pence each

Identification code

GB0002183191

b)

Nature of the Transaction

Exercise of Options

c)

Price(s) and volume(s)

Price(s)

Volume(s)

39 pence

400,000 ordinary shares

d)

Aggregated information

Aggregated volume price

N/A - Single Transaction

e)

Date of the transaction

26 May 2020

f)

Place of the transaction

London Stock Exchange, AIM (LON:CNC)

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Jane Annear

2.

Reason for the Notification

a)

Position/status

Director

b)

Initial notification/amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Concurrent Technologies Plc

b)

LEI

213800422HXP2X6UPD94

4.

Details of the transaction(s):section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv)each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary shares of 1 pence each

Identification code

GB0002183191

b)

Nature of the Transaction

Transfer of shares from Mrs Annear's personal share dealing account to an ISA in her name

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Sale from personal account at 114.00 pence

11,500 Ordinary Shares

Acquisition into ISA at 114.25 pence per Ordinary Share

11,500 Ordinary Shares

d)

Aggregated information

Aggregated volume price

Aggregate number of Ordinary Shares sold: 11,500

Aggregate number of Ordinary Shares acquired: 11,500

Aggregate sale price: £13,110.00

Aggregate acquisition price: £13,138.75

 

e)

Date of the transaction

27 May 2020

f)

Place of the transaction

London Stock Exchange, AIM (LON:CNC)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TVREASSXASDEEFA
Date   Source Headline
30th Mar 201711:18 amRNSHolding(s) in Company
29th Mar 20174:33 pmRNSHolding(s) in Company
24th Mar 20177:00 amRNSFinal Results
22nd Mar 20177:00 amRNSNotice of Results
2nd Mar 201710:11 amRNSProduct Announcement
24th Feb 20177:00 amRNSSecond Interim Dividend
30th Jan 20179:23 amRNSProduct Announcement
13th Jan 20179:30 amRNSHolding(s) in Company
13th Jan 20179:30 amRNSHolding(s) in Company
20th Dec 20162:36 pmRNSPre-Close Trading Update
16th Dec 20163:13 pmRNSDirector/PDMR Shareholding
1st Nov 20167:00 amRNSProduct Launch
29th Sep 20167:00 amRNSProduct Launch
22nd Sep 20162:45 pmRNSTotal Voting Rights
9th Sep 201612:05 pmRNSDirector/PDMR Shareholding
30th Aug 20165:05 pmRNSHolding(s) in Company
30th Aug 201612:59 pmRNSHolding(s) in Company
26th Aug 20167:00 amRNSInterim Results
19th Aug 20162:21 pmRNSNotice of Interim Results
22nd Jul 20161:55 pmRNSHolding(s) in Company
1st Jul 20167:00 amRNSTrading Update
1st Jun 20162:43 pmRNSTotal Voting Rights
19th May 201612:56 pmRNSAGM Statement
12th May 20165:18 pmRNSDirector/PDMR Shareholding
6th May 20167:00 amRNSProduct Launch
19th Apr 20163:51 pmRNSDirector/PDMR Shareholding
19th Apr 201612:10 pmRNSDirector/PDMR Shareholding
18th Apr 20162:14 pmRNSDirector/PDMR Shareholding
18th Apr 201610:55 amRNSPosting of Annual Report & Accounts
29th Mar 20164:53 pmRNSHolding(s) in Company
24th Mar 201612:55 pmRNSHolding(s) in Company
21st Mar 20163:20 pmRNSHolding(s) in Company
18th Mar 20167:00 amRNSResults for the year ended 31 December 2015
14th Mar 201612:20 pmRNSNotice of Results
19th Jan 201610:18 amRNSProduct Launch
23rd Dec 20159:59 amRNSDirector/PDMR Shareholding
16th Dec 20153:22 pmRNSPre-Close Trading Update
19th Nov 20152:19 pmRNSDirector/PDMR Shareholding
10th Nov 20157:00 amRNSProduct Launch
20th Oct 201511:35 amRNSTotal Voting Rights
14th Oct 20151:00 pmRNSProduct Launch
15th Sep 20152:09 pmRNSTransaction in Own Shares
14th Sep 20154:59 pmRNSTransaction in Own Shares
2nd Sep 20159:05 amRNSProduct Update
2nd Sep 20157:00 amRNSHalf Yearly Report
19th Aug 201511:13 amRNSNotice of Interim Results
27th May 20154:08 pmRNSResult of AGM
26th May 201512:37 pmRNSAGM Statement
21st May 20157:00 amRNSTrading Update
5th May 201510:40 amRNSPosting of Annual Report & Accounts

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.